Cardinal Health, Inc. (CAH) receives an Outperform rating from Leerink Partners
Cardinal Health, Inc.’s filing revealed that its CEO, Pharmaceutical Segment WEITZMAN DEBORAH unloaded Company’s shares for reported $3.9 million on Nov 27 ’23. In the deal valued at $106.31 per share,36,642 shares were sold. As a result of this transaction, WEITZMAN DEBORAH now holds 35,202 shares worth roughly $3.62 million. Then, WEITZMAN DEBORAH sold 6,712 […]
Cardinal Health, Inc. [NYSE: CAH] Sees Decrease in Stock Value
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Cardinal Health, Inc. shares valued at $3,895,411 were sold by WEITZMAN DEBORAH on Nov 27 ’23. At $106.31 per share, WEITZMAN DEBORAH sold 36,642 shares. The insider’s holdings dropped to 35,202 shares worth approximately $3.73 million following […]
Taking a Closer Look At Cardinal Health, Inc. (CAH) Following Its Recent Trade
Cardinal Health, Inc.’s recently made public that its CEO, Pharmaceutical Segment WEITZMAN DEBORAH unloaded Company’s shares for reported $3.9 million on Nov 27 ’23. In the deal valued at $106.31 per share,36,642 shares were sold. As a result of this transaction, WEITZMAN DEBORAH now holds 35,202 shares worth roughly $3.77 million. Then, WEITZMAN DEBORAH sold […]
Positive sentiment towards CAH reflected by a fall of -17.81% in short interest
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Cardinal Health, Inc. shares valued at $3,895,411 were sold by WEITZMAN DEBORAH on Nov 27 ’23. At $106.31 per share, WEITZMAN DEBORAH sold 36,642 shares. The insider’s holdings dropped to 35,202 shares worth approximately […]
CAH (Cardinal Health, Inc.) may reap gains as insiders became active recently
In a filing, Cardinal Health, Inc. revealed its CEO, Pharmaceutical Segment WEITZMAN DEBORAH unloaded Company’s shares for reported $3.9 million on Nov 27 ’23. In the deal valued at $106.31 per share,36,642 shares were sold. As a result of this transaction, WEITZMAN DEBORAH now holds 35,202 shares worth roughly $3.85 million. Then, WEITZMAN DEBORAH sold […]
Insider Selling: WEITZMAN DEBORAH, Cardinal Health, Inc. [CAH] CEO, Pharmaceutical Segment divested 36,642 shares
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Cardinal Health, Inc. shares valued at $3,895,411 were sold by WEITZMAN DEBORAH on Nov 27 ’23. At $106.31 per share, WEITZMAN DEBORAH sold 36,642 shares. The insider’s holdings dropped to 35,202 shares worth approximately […]
Cardinal Health, Inc. (CAH) receives an Outperform rating from Leerink Partners
In a filing, Cardinal Health, Inc. revealed its CEO, Pharmaceutical Segment WEITZMAN DEBORAH unloaded Company’s shares for reported $3.9 million on Nov 27 ’23. In the deal valued at $106.31 per share,36,642 shares were sold. As a result of this transaction, WEITZMAN DEBORAH now holds 35,202 shares worth roughly $3.94 million. Then, WEITZMAN DEBORAH sold […]
Cardinal Health, Inc. (CAH) may enjoy gains as insiders got busy in the recent days
Cardinal Health, Inc.’s recently made public that its CEO, Pharmaceutical Segment WEITZMAN DEBORAH unloaded Company’s shares for reported $3.9 million on Nov 27 ’23. In the deal valued at $106.31 per share,36,642 shares were sold. As a result of this transaction, WEITZMAN DEBORAH now holds 35,202 shares worth roughly $3.91 million. Then, WEITZMAN DEBORAH sold […]
Cardinal Health, Inc. [CAH] Shares Jump Approximately 55.73% Over the Year
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Cardinal Health, Inc. shares valued at $3,895,411 were sold by WEITZMAN DEBORAH on Nov 27 ’23. At $106.31 per share, WEITZMAN DEBORAH sold 36,642 shares. The insider’s holdings dropped to 35,202 shares worth approximately $3.96 million following […]
